Clinical trial Recruiting at 1 site Interventional Ages 75 and up

How Bleeding Affects Delirium in Older Adults After Hip Fracture

Official title: The Impact of Bleeding on Delirium Outcomes in Older Patients With Hip Fractures: A Single-Blind, Randomized Controlled Trial - The IMPROVE-HIP Study

Run by University of Aarhus · NCT06938789 · Data updated 2026-11-12

This trial tests whether early detection of bleeding and prompt blood transfusions can lower delirium risk in people 75 and older with hip fractures.

More Bleeding trials

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment198 (estimated)
SponsorUniversity of Aarhus
Academic / other
Locations2 sites (Aarhus, Central Jutland and 1 other locations)
StatusRecruiting
StartedApril 24, 2025
Main results expectedDecember 31, 2026
Study endsJune 1, 2027
Registry record updatedMay 22, 2026
Trial IDNCT06938789 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 75 and older with a hip fracture undergoing surgery, who can participate in frequent delirium screening and consent to blood transfusion if needed.

Probably not a fit

Patients with limitations preventing transfusion, severe dementia with disruptive behavior, or those who decline transfusions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study explores whether early identification of bleeding and rapid red blood cell transfusions reduce delirium after hip fracture surgery in older adults. Participants will have regular blood tests, continuous vital-sign monitoring, and delirium screening every 8 hours for the first 48 hours post-surgery. They will receive transfusions promptly if their hemoglobin falls below a defined threshold, with follow-up assessments at 30 and 90 days to evaluate cognitive function, quality of life, hospital readmissions, and survival. The study compares early diagnosis and treatment of anemia to standard care to determine impact on delirium incidence. Primary setting includes Aarhus University Hospital, Gødstrup Hospital, and related departments in Denmark.

Why it matters

Potential benefit: If successful, patients may have a lower risk of delirium and better short-term cognitive and functional outcomes after hip fracture surgery.

How similar studies have gone: Previous work in perioperative care supports monitoring for bleeding and transfusion strategies, but this specific early-detection, early-transfusion approach for delirium prevention in this population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hip fracture

Exclusion Criteria:

* Pathological hip fracture
* Periprosthtic fracture
* Unable to speak or understand Danish
* Does not wish to recieve blood transfusion
* If the investigator finds the patient unable to cooperate to the study (e.g. in case of severe dementia and externalizing behaviour)

Where it's running

  • Gødstrup Hospital, Department of internal medicine
    Herning, Central Jutland, Denmark
    Recruiting
  • Aarhus University Hospital
    Aarhus, Central Jutland, Denmark
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.